State-by-State Telehealth Advertising Rules — What Changes by Market

Federal advertising rules apply nationwide, but state telehealth and pharmacy laws add another layer of compliance that most brands miss. California restricts compounded medication advertising. Texas has specific telehealth practice requirements. New York requires additional disclosures for online pharmacies. Meta and Google enforce state-level rules even when brands assume federal law is the only standard. This guide breaks down the state-specific advertising restrictions that affect telehealth brands based on managing campaigns across all 50 states.

Why State Laws Matter for Digital Advertising

Most telehealth brands assume FDA and FTC rules are the only regulations that apply to advertising. That is wrong. States regulate telehealth practice, pharmacy operations, and healthcare advertising within their borders. If your ads target patients in a state with restrictive laws, you must comply with both federal and state rules.

Platforms like Meta and Google enforce state regulations to avoid liability. If California prohibits compounded medication advertising and you target California patients with compounded drug ads, Meta will flag your ads as non-compliant. The fact that your ads are legal under federal law does not matter if they violate state law.

California: Strictest Compounding Pharmacy Rules

California Business and Professions Code Section 4126 prohibits advertising compounded drugs that are essentially copies of commercially available FDA-approved products. If an FDA-approved version of the drug exists and is available, California pharmacies generally cannot advertise the compounded version.

What this means for telehealth brands: If your brand offers compounded semaglutide, you cannot advertise it in California. Ozempic and Wegovy are commercially available FDA-approved semaglutide products, which means advertising compounded semaglutide violates California law. The same applies to compounded testosterone, sildenafil, tadalafil, and finasteride.

How to stay compliant: Exclude California from targeting for compounded medication ads. If your service offers both FDA-approved and compounded medications, advertise only the FDA-approved products in California.

Exceptions: If the compounded medication is customized for a patient's specific needs (different dosage, different formulation), it may be advertised. But the ad must clarify that compounding is done for medical necessity, not cost savings or availability.

Texas: Telehealth Practice and Pharmacy Advertising Restrictions

Texas requires that telehealth providers establish a proper physician-patient relationship before prescribing. That means initial consultations must include a real-time video or in-person visit, not just a questionnaire. Texas also restricts compounding pharmacy advertising and requires specific disclosures.

What this means for telehealth brands: If your telehealth model relies on asynchronous consultations (questionnaire-based evaluations), you cannot offer services to Texas patients unless you modify your process. Your ads must clarify that treatment requires a live consultation with a licensed Texas provider.

How to stay compliant: Ensure your Texas-based providers conduct real-time video consultations. Update your ad copy to clarify "live consultation required" when targeting Texas. Do not advertise questionnaire-based prescriptions to Texas patients.

New York: Online Pharmacy Disclosure Requirements

New York requires online pharmacies to register with the State Board of Pharmacy and display specific information on their websites. If you advertise pharmacy services in New York, your landing pages must include licensing information, physical address, and contact details for the pharmacist-in-charge.

What this means for telehealth brands: Your New York landing pages must meet state pharmacy disclosure requirements. If your ads direct patients to a checkout flow that does not include required disclosures, you are non-compliant.

How to stay compliant: Add New York-specific landing pages that include pharmacy licensing information, physical address, and pharmacist contact details. Link to these pages from ads targeting New York patients.

Florida: Telehealth Practice Standards and Compounding Rules

Florida requires telehealth providers to meet specific standards for establishing physician-patient relationships. The state also regulates compounding pharmacy advertising and prohibits false or misleading claims about compounded medications.

What this means for telehealth brands: Your Florida providers must follow Florida Board of Medicine telehealth standards. Your compounded medication ads must include disclaimers that compounded drugs are not FDA-approved and may differ from commercial products.

How to stay compliant: Review Florida Board of Medicine telehealth practice guidelines. Ensure your consultation process meets Florida standards. Add compounding disclaimers to all ads targeting Florida patients.

States with Restrictive Controlled Substance Prescribing

Some states restrict telehealth prescribing for controlled substances like testosterone (Schedule III). These states may require in-person visits before initial prescriptions or limit refills through telehealth.

States with stricter controlled substance telehealth rules: Arkansas, Louisiana, Missouri, Oklahoma, West Virginia.

What this means for TRT telehealth brands: If you offer testosterone therapy, you may need to exclude certain states from targeting or modify your service model to include in-person components.

How to stay compliant: Review each state's controlled substance telehealth prescribing rules. Exclude states where your model does not comply. Update your ads to clarify that in-person visits may be required in some states.

How to Build a State Compliance Map

Step 1: Identify which states have restrictive telehealth or pharmacy laws. Focus on the top 10 states by population: California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, Georgia, North Carolina, Michigan. These states represent the majority of your patient volume.

Step 2: Determine which restrictions apply to your service. If you offer compounded medications, California is a high-priority compliance issue. If you offer controlled substances like testosterone, check state prescribing rules.

Step 3: Update your ad targeting to exclude non-compliant states. If you cannot comply with a state's rules, exclude that state from targeting. The revenue loss is smaller than the compliance risk.

Step 4: Create state-specific landing pages where required. New York, California, and Texas may require different landing page content. Build state-specific pages that meet local disclosure requirements.

Step 5: Review and update quarterly. State laws change. New telehealth regulations pass every year. Review your state compliance map quarterly and update targeting as needed.

What to Do If Your Ads Violate State Rules

If Meta or Google flags your ads for state compliance violations, do not appeal without fixing the underlying issue. Platforms check state regulations as part of their review process. If your service model violates state law, the appeal will fail.

Option 1: Modify your service to comply with state rules. Add live video consultations for Texas. Stop advertising compounded medications in California. Update landing pages for New York.

Option 2: Exclude non-compliant states from targeting. If you cannot modify your service, exclude states where your model is non-compliant. Update your ad targeting to remove those states.

Option 3: Consult a healthcare attorney. If state compliance issues are blocking significant revenue, hire an attorney who specializes in telehealth and pharmacy law. They can advise on service modifications or legal workarounds.

Why Most Telehealth Brands Ignore State Compliance

State-level compliance is harder to track than federal rules. FDA and FTC publish clear guidance documents. State regulations are buried in pharmacy board rules, medical board guidelines, and state statutes. Most telehealth marketers do not have time to review 50 different state codes.

The brands that scale successfully hire compliance consultants or attorneys to review state rules. The cost of professional compliance review is lower than the cost of lost ad accounts, legal enforcement, or state board investigations.

For more on telehealth advertising compliance, see our guides on Meta ad policies, FDA advertising rules, and compounding pharmacy advertising. If you need help building a compliance process, read compliance review systems. More at our compliance hub.

Need telehealth advertising strategy that complies with state and federal rules? We build compliant campaigns for prescription telehealth brands exclusively. Book a strategy call.